A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study.
作者:
主题词
人类(Humans);呼吸道合胞病毒疫苗(Respiratory Syncytial Virus Vaccines);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);男(雄)性(Male);女(雌)性(Female);老年人(Aged);痘苗病毒(Vaccinia virus);抗体, 病毒(Antibodies, Viral);呼吸道合胞体病毒, 人(Respiratory Syncytial Virus, Human);中年人(Middle Aged);疫苗, 合成(Vaccines, Synthetic);双盲法(Double-Blind Method);老年人, 80以上(Aged, 80 and over);抗体, 中和(Antibodies, Neutralizing);疫苗, 减毒(Vaccines, Attenuated);遗传载体(Genetic Vectors)
DOI
10.1016/j.vaccine.2024.126427
PMID
39461302
发布时间
2025-01-10
- 浏览0

Vaccine
126427页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文